ScreenPoint Medical

ScreenPoint Medical is a Netherlands-based healthcare AI company, founded in 2014 by Professor Nico Karssemeijer and Professor Sir Michael Brady, that develops Transpara Breast AI for earlier detection of breast cancer in 2D (FFDM) and 3D (DBT) mammography. Transpara is vendor-agnostic, integrates into PACS and reading workflows via medical-imaging (DICOM) pipelines rather than a public developer API, and is FDA cleared (K241831, K232096) and CE marked (0344). The product is used in over 200 clinics across 25+ countries and is backed by three randomized controlled trials (including MASAI in The Lancet). The company is backed by Insight Partners. This profile was enriched by the API Evangelist pipeline: no public developer/API surface exists, but real security-disclosure and compliance posture were captured.

ScreenPoint Medical is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Artificial Intelligence, Medical Imaging, and Mammography.

ScreenPoint Medical’s developer surface includes engineering blog and 7 more developer resources.

🌐 Visit website 📡 Source on GitHub
18.9/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyHealthcareArtificial IntelligenceMedical ImagingMammographyBreast CancerRadiologyMachine Learning

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 18.9/100 · emerging
Contract Quality 0.0 / 25
Developer Ergonomics 0.4 / 20
Commercial Clarity 3.7 / 20
Operational Transparency 1.4 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/screenpoint-medical: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 2

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Screenpoint Medical Domain Security

TLSv1.3 · HSTS · DNSSEC · DMARC

SECURITY

Screenpoint Medical Vulnerability Disclosure

contact published

SECURITY

Resources

Design & Contract 1

Pagination, idempotency, versioning, errors, and events

Conformance
Conformance

Access & Security 4

Authentication, authorization, and security posture

Security
Security
 Compliance
Compliance
 VulnerabilityDisclosure
VulnerabilityDisclosure
 DomainSecurity
DomainSecurity

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy

Company 2

The organization behind the API

Website
Website
 Blog
Blog

Source (apis.yml)

apis.yml Raw ↑ 
aid: screenpoint-medical
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/screenpoint-medical.png
name: ScreenPoint Medical
description: 'ScreenPoint Medical is a Netherlands-based healthcare AI company, founded in 2014 by Professor Nico Karssemeijer
  and Professor Sir Michael Brady, that develops Transpara Breast AI for earlier detection of breast cancer in 2D (FFDM) and
  3D (DBT) mammography. Transpara is vendor-agnostic, integrates into PACS and reading workflows via medical-imaging (DICOM)
  pipelines rather than a public developer API, and is FDA cleared (K241831, K232096) and CE marked (0344). The product is
  used in over 200 clinics across 25+ countries and is backed by three randomized controlled trials (including MASAI in The
  Lancet). The company is backed by Insight Partners. This profile was enriched by the API Evangelist pipeline: no public
  developer/API surface exists, but real security-disclosure and compliance posture were captured.'
url: https://raw.githubusercontent.com/api-evangelist/screenpoint-medical/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- insight-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Healthcare
- Artificial Intelligence
- Medical Imaging
- Mammography
- Breast Cancer
- Radiology
- Machine Learning
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://screenpoint-medical.com/
- type: Blog
  url: https://screenpoint-medical.com/insights
- type: PrivacyPolicy
  url: https://screenpoint-medical.com/privacy-policy-screenpoint-medical
- type: Security
  url: https://screenpoint-medical.com/security-reporting
- type: Compliance
  url: https://screenpoint-medical.com/security-reporting
- type: VulnerabilityDisclosure
  url: security/screenpoint-medical-vulnerability-disclosure.yml
- type: DomainSecurity
  url: security/screenpoint-medical-domain-security.yml
- type: Conformance
  url: conformance/screenpoint-medical-conformance.yml
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 3
  pass: local-v1